Korro Bio (KRRO) Non-Current Debt (2018 - 2022)
Korro Bio's (KRRO) quarterly Non-Current Debt came in at $4.2 million in Q4 2022, down 70.59% YoY from $14.2 million in Q4 2021, and down 37.5% on a QoQ basis from $6.7 million in Q3 2022.
Korro Bio (KRRO) Non-Current Debt (2018 - 2022) Analysis & Trends
Korro Bio (KRRO) has 5 years of Non-Current Debt data on file, last reported at $4.2 million in Q4 2022.
- Quarterly Non-Current Debt fell 70.59% year-over-year to $4.2 million in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $4.2 million (down 70.59% YoY) and the FY2022 annual result came in at $4.2 million, down 70.59% from the prior year.
- Non-Current Debt fell to $4.2 million in Q4 2022, from $6.7 million in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $15.0 million in Q4 2020 to a low of $180000.0 in Q4 2019.
- A 5-year average of $8.9 million and a median of $10.4 million in 2022 frame the typical range for Non-Current Debt.
- Annual changes were most pronounced in 2020 — Non-Current Debt jumped 8233.33% — and 2022, when it slumped 70.59%.
- Tracing KRRO's Non-Current Debt over 5 years: stood at $349000.0 in 2018, then sank by 48.42% to $180000.0 in 2019, then jumped by 8233.33% to $15.0 million in 2020, then retreated by 5.55% to $14.2 million in 2021, then slumped by 70.59% to $4.2 million in 2022.
- The last three Non-Current Debt figures came in at $4.2 million (Q4 2022), $6.7 million (Q3 2022), and $9.2 million (Q2 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.23 Bn | 132.38 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.97 Bn | 78.97 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 65.29 Bn | 60.11 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.88 Bn | 54.74 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 42.20 Bn | 37.11 Bn | 1.53 Bn | 882.16 Mn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.69 Bn | 10.30 Bn | 668.28 Mn | 360.97 Mn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn | 546.77 Mn |
| 9 | Royalty Pharma | 27.16 Bn | 26.33 Bn | - | 8.96 Bn |
| 10 | Korro Bio | 232.92 Mn | 117.88 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 4.17 Mn |
| Sep 30, 2022 | 6.67 Mn |
| Jun 30, 2022 | 9.17 Mn |
| Mar 31, 2022 | 11.67 Mn |
| Dec 31, 2021 | 14.17 Mn |
| Sep 30, 2021 | 15.00 Mn |
| Jun 30, 2021 | 15.00 Mn |
| Mar 31, 2021 | 15.00 Mn |
| Dec 31, 2020 | 15.00 Mn |
| Dec 31, 2019 | 180,000.00 |
| Sep 30, 2019 | 222,000.00 |
| Dec 31, 2018 | 349,000.00 |